193 related articles for article (PubMed ID: 9059936)
21. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human cardiac infiltrating cells post transplantation. 1. Phenotypic and functional alloreactivity.
Ahmed-Ansari A; Tadros T; Dempsey CL; Knopf WD; Leatherbury A; Gravanis MB; Murphy DA; Goodroe JH; Sell KW
Am J Cardiovasc Pathol; 1988; 2(3):193-210. PubMed ID: 3064770
[TBL] [Abstract][Full Text] [Related]
23. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
[TBL] [Abstract][Full Text] [Related]
24. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation.
Sell KW; Tadros T; Wang YC; Hertzler G; Knopf WD; Murphy DA; Ahmed-Ansari A
J Heart Transplant; 1988; 7(6):407-18. PubMed ID: 2463352
[TBL] [Abstract][Full Text] [Related]
25. The effect of antithymocyte globulin therapy on frequency and avidity of allospecific committed CTL in clinical heart transplants.
Baan CC; Vaessen LM; Loonen EH; Balk AH; Jutte NH; Claas FH; Weimar W
Transplant Proc; 1995 Feb; 27(1):482-4. PubMed ID: 7879069
[No Abstract] [Full Text] [Related]
26. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
27. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ
J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919
[TBL] [Abstract][Full Text] [Related]
28. Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation.
Van Hoffen E; Gmelig-Meyling FH; Bosboom-Kalsbeek KC; Hu H; De Jonge N; Tilanus MG; Lahpor JR; De Weger RA
J Heart Lung Transplant; 1997 Feb; 16(2):216-21. PubMed ID: 9059933
[TBL] [Abstract][Full Text] [Related]
29. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
Marzo AL; Lake RA; Robinson BW; Scott B
Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
[TBL] [Abstract][Full Text] [Related]
30. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
31. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
32. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
33. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
34. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
35. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
[TBL] [Abstract][Full Text] [Related]
36. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
[TBL] [Abstract][Full Text] [Related]
37. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
38. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
39. C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejection.
van Emmerik NE; Knoop CJ; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
Transplantation; 1998 Jul; 66(1):135-8. PubMed ID: 9679837
[TBL] [Abstract][Full Text] [Related]
40. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
